Total Payments
$1,129
2024 Payments
$82.46
Companies
22
Transactions
71
Medicare Patients
2,446
Medicare Billing
$182,717
Payment Breakdown by Category
Food & Beverage$1,129 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,129 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $252.82 | 19 | $0 (2024) |
| Novo Nordisk Inc | $168.18 | 11 | $0 (2024) |
| Lilly USA, LLC | $87.12 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $82.66 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $74.32 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $61.04 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $53.41 | 4 | $0 (2023) |
| PFIZER INC. | $49.61 | 3 | $0 (2023) |
| Amarin Pharma Inc. | $40.21 | 3 | $0 (2020) |
| Bausch Health US, LLC | $39.95 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.46 | 5 | Novo Nordisk Inc ($37.25) |
| 2023 | $156.22 | 9 | Lilly USA, LLC ($43.46) |
| 2022 | $226.95 | 16 | ABBVIE INC. ($73.01) |
| 2021 | $316.40 | 24 | AbbVie Inc. ($166.52) |
| 2020 | $262.88 | 14 | Gilead Sciences, Inc. ($74.32) |
| 2019 | $61.04 | 1 | GlaxoSmithKline, LLC. ($61.04) |
| 2017 | $22.58 | 2 | Janssen Pharmaceuticals, Inc ($22.58) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.20 | General |
| 04/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 12/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.51 | General |
| 11/01/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: PAIN | ||||||
| 09/06/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/26/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Neuroscience | ||||||
| 07/12/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/09/2023 | Baxter Healthcare | ADEPT (Device) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Surgical Care | ||||||
| 04/19/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Neuroscience | ||||||
| 03/29/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Neuroscience | ||||||
| 02/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 07/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 06/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PSYCHIATRY | ||||||
| 05/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Central Nervous System | ||||||
| 04/20/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 51 | $18,071 | $5,544 |
| 2022 | 4 | 220 | 227 | $75,790 | $22,767 |
| 2021 | 14 | 948 | 1,026 | $193,030 | $66,995 |
| 2020 | 18 | 1,239 | 1,361 | $295,885 | $87,412 |
Total Patients
2,446
Total Services
2,665
Medicare Billing
$182,717
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 34 | $10,914 | $3,184 | 29.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $7,157 | $2,360 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 85 | 85 | $32,300 | $12,129 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 116 | $41,760 | $9,463 | 22.7% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 15 | 15 | $630.00 | $610.81 | 97.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 11 | 11 | $1,100 | $563.39 | 51.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 260 | $93,600 | $23,249 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $40,830 | $15,455 | 37.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 70 | 70 | $6,300 | $4,564 | 72.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 23 | 23 | $12,995 | $4,235 | 32.6% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 192 | 192 | $3,840 | $3,767 | 98.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 60 | 60 | $6,000 | $3,079 | 51.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 36 | 36 | $9,000 | $2,919 | 32.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 95 | 95 | $2,850 | $2,850 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 31 | $7,595 | $2,265 | 29.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 31 | 32 | $4,800 | $2,001 | 41.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 72 | 73 | $3,650 | $1,425 | 39.0% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 20 | 20 | $1,000 | $917.00 | 91.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 11 | $330.00 | $214.83 | 65.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 16 | $240.00 | $55.68 | 23.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 243 | 336 | $120,960 | $25,727 | 21.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 193 | 219 | $53,655 | $13,008 | 24.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 85 | 85 | $32,300 | $10,638 | 32.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 154 | 154 | $13,860 | $9,312 | 67.2% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 152 | 153 | $15,260 | $7,850 | 51.4% |
About Dr. Beth Greenwood, MD
Dr. Beth Greenwood, MD is a Family Medicine healthcare provider based in Haddon Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1578798617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Greenwood, MD has received a total of $1,129 in payments from pharmaceutical and medical device companies, with $82.46 received in 2024. These payments were reported across 71 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,129).
As a Medicare-enrolled provider, Greenwood has provided services to 2,446 Medicare beneficiaries, totaling 2,665 services with total Medicare billing of $182,717. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Haddon Heights, NJ
- Active Since 05/19/2009
- Last Updated 08/09/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578798617
Products in Payments
- VRAYLAR (Drug) $227.66
- Ozempic (Drug) $85.37
- Descovy (Drug) $74.32
- UBRELVY (Drug) $63.67
- BEXSERO (Biological) $61.04
- FARXIGA (Drug) $53.41
- EMGALITY (Drug) $43.46
- BELSOMRA (Drug) $40.30
- Vascepa (Drug) $40.21
- ADEPT (Device) $30.74
- Rybelsus (Drug) $29.05
- TRULICITY (Drug) $28.41
- WELLBUTRIN (Drug) $28.23
- NURTEC ODT (Drug) $22.76
- INVOKANA (Drug) $22.58
- Dexcom G6 Transmitter (Medical Supply) $17.57
- AFREZZA (Drug) $15.82
- XIFAXAN (Drug) $15.43
- MOUNJARO (Drug) $15.25
- (8874) inCourage (Device) $14.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Haddon Heights
Sangita Doshi, Md, MD
Family Medicine — Payments: $1,282
Family Medicine $1,282
Leena Jacob, D.o, D.O
Family Medicine — Payments: $640.59
Family Medicine $640.59
Nancy Koshy
Family Medicine — Payments: $462.15
Family Medicine $462.15
Dr. Frank Anthony Aliganga, Md, MD
Family Medicine — Payments: $61.92
Family Medicine $61.92
Dr. Alexander Higgins, M.d, M.D
Family Medicine — Payments: $47.88
Family Medicine $47.88
Dr. Mary Willard, M.d, M.D
Family Medicine
Family Medicine